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Abstract: 
 
 Meditation refers to a family of practices that may share many similarities, but can have 
differences in underlying methods and goals.  Religious and spiritual associations are common 
but are not requisite for meditation practice and it should be recognized that the basis of many if 
not all practices is the training of the brain and body, a process that appears to have profound 
effects on both structure and function.  In recent decades there has been interest regarding the 
effects of these ancient practices on the cardiovascular system, as meditation has intuitive appeal 
for benefit in this area.  Though there is a relative shortage of quality data, available evidence 
suggests that meditation may exert beneficial effects on autonomic tone, autonomic reflexes, and 
decrease blood pressure acutely and after long term practice.  In addition, meditation has the 
potential to positively influence the cardiovascular system through mind-heart connection and 
the anti-inflammatory reflex.  There is limited but promising data to suggest that meditation 
based interventions can have beneficial effects on patients with established cardiovascular 
disease.  More high quality and unbiased studies of meditation practices on relevant endpoints in 
cardiovascular disease are needed, including the effects of such practices on inflammation, 
baseline heart rate variability, arrhythmias, myocardial infarction, and cardiovascular mortality. 
 
Key words: meditation, cardiovascular disease, autonomic dysfunction, inflammation, mind-
heart connection 
  
 Meditation refers to a family of practices that may share many similarities, but can have 
differences in underlying methods and goals.  The absence of a succinct yet thorough definition 
of meditation as well as a lack of exposure likely contribute to misconceptions regarding the 
practices in both the lay and scientific communities.  The initial goal here is not to attempt the 
daunting task of providing a thorough definition of meditation or to introduce a classification 
system, but to give a brief overview of the building blocks of common meditation practices and 
how they might relate to the cardiovascular system and cardiovascular health.   
 Meditative practices may involve focused attention during which the practitioner directs 
his or her consciousness on breathing, an object, or a word or phrase known as a mantra.  The 
focus of attention can also involve a greater awareness of all thoughts, emotions, and sensations 
that the individual has in a practice known as mindfulness meditation.  Other practices strive to 
cultivate particular feelings such as love or compassion for self and others. 
 Many meditation practices place emphasis on experiencing the present moment.  To 
counteract the natural tendency of the human mind to think about the past or future, skill in 
concentration is developed to allow the practitioner to focus primarily on immediate conscious 
phenomena.  The inevitable wandering of the mind is acknowledged when it is noted to occur 
and attention is then directed back to where it is intended to be.  This process occurs time and 
again and serves to strengthen concentration and ultimately the connection with the present 
moment.  In more intense practices, the mental state of “thoughtless awareness” with a deep 
sense of physical and mental calm and enhanced pure awareness may result.
1 
 Though most often associated with Buddhism and Hinduism, meditative practices are 
also found in many if not all of the major religions of the world.  Often, such practices include 
specific content that is related to the religious tradition.  However, meditation practices may have 
  
spiritual meaning for those that practice in the absence of a formal religious belief system.  Many 
practices today, including mindfulness or yoga based practices, are quite secularized compared to 
their traditions of origin.  Thus, religious and spiritual associations are not requisite for practice 
and it should be recognized that the basis of many if not all practices is the training of the brain 
and body, a process that appears to have profound effects on both structure and function.  
 For thousands of years those that practice meditation have believed in the beneficial 
effects on the mind and body.  Within the last half century, there has been an increase in 
scientific research that has studied the physiology of meditation practices and their effects in 
health and disease.  There has been recent interest regarding the effects of meditation on the 
cardiovascular system, as meditation has intuitive appeal for benefit in this area.  This review 
will explore the theoretical rationale and supporting data for the ability of meditation to exert a 
positive influence on the cardiovascular system and assess the current body of research on 
meditation in patients with cardiovascular disease.  While movement based practices such as 
yoga or tai chi have meditative components, this review will focus on stationary meditation 
practices. 
The Autonomic Nervous System  
 Chronic imbalance of the autonomic nervous system in the form of increased sympathetic 
tone and/or decreased parasympathetic tone is a powerful risk factor for cardiovascular morbidity 
and mortality.
2,3
  Sympathetic activation increases cardiovascular workload and contributes to 
endothelial dysfunction, coronary spasm, left ventricular hypertrophy, myocardial infarction, 
arrhythmias, and sudden death.
3
  Diverse factors that negatively affect the autonomic nervous 
system balance including insulin resistance and metabolic syndrome, sympathomimetic 
medications or recreational drugs, and acute and chronic psychosocial stressors are associated 
  
with increased risk of cardiovascular events.  Conversely, therapies that offer a more favorable 
autonomic balance such as exercise, beta-blockers, and angiotensin converting enzyme inhibitors 
can reduce cardiovascular morbidity and mortality.
3
  Described as a wakeful hypometabolic 
state
4
, meditation practices can acutely exert significant influence on autonomic tone with 
parasympathetic activation.
5
  The regular practice of meditation may favorably affect baseline 
autonomic balance
6
, though this requires further study.
 
Heart Rate Variability and Autonomic Reflexes 
 Heart rate variability, a measure of the variation of instantaneous heart rate over 
time, can provide a window into the functioning of the autonomic nervous system and 
autonomic balance.  Low heart rate variability has been associated with increased risk of 
cardiovascular events and mortality, and has also been associated with a poor prognosis in 
heart failure and post myocardial infarction.
7-11
 Increased HRV appears cardioprotective 
in most, but not all groups (for example, those with sinus node dysfunction), as 
demonstrated in the Rotterdam Study.
12
 
 Three sub-bands of heart rate variability of particular interest include high 
frequency oscillations (0.15 - 0.4 Hz), low frequency oscillations (0.04 - 0.15 Hz), and very 
low frequency oscillations (0.0033 - 0.04 Hz).
13 
  A thorough discussion of heart rate 
variability is outside the scope of this review, therefore only the more relevant points will 
be discussed here.  Respiratory sinus arrhythmia (RSA) is the normal physiologic 
phenomenon during which the heart rate increases with inspiration and decreases with 
expiration.  As vagal activity is a major contributor to RSA, the phenomenon has been 
utilized as a marker of parasympathetic tone.
13
 At normal breathing rates, these 
respiratory oscillations fall into the high frequency sub-band and consequently high 
  
frequency heart rate variability is thought to reflect parasympathetic tone.  The origin of 
inherent low frequency oscillations is controversial but the dominant theory postulates that 
the baroreflex is responsible for low frequency variation through a feedback loop while 
another theory holds that low frequency oscillations are generated by a central brain stem 
oscillator.
14
 Interpretation of the significance of low frequency oscillations is also 
controversial; low frequency variability is thought to reflect either autonomic balance or 
sympathetic activity.  The significance of very low frequency oscillations is uncertain.
13
 
 During meditation, the respiratory rate commonly decreases and heart rate variability 
from RSA may decrease to the low frequency range of heart rate variability.  At approximately 6 
breaths per minute or 0.1 Hz,  RSA synchronizes with inherent low frequency variability leading 
to significantly increased amplitude of heart rate variability.
15-19
 (Figure 1)  This is the same 
physiology that occurs during biofeedback training to increase heart rate variability.
20
  A rate of 
breathing of 6 breaths per minute or 0.1 Hz also coincides with and augments the intrinsic blood 
pressure variation known as the Mayer wave
21
, a complex phenomenon of autonomic activity 
that results in an approximately 10 second cycle (0.1 Hz or 6 per minute) of blood pressure.
22
  Of 
interest, it has been shown that during recitation of the Ave Maria in Latin and during recitation 
of a yoga mantra subjects spontaneously decreased their respiratory rate to 6 breaths per minute, 
which augmented heart rate variability and Mayer wave amplitude and even resulted in rhythmic 
fluctuations in cerebral blood flow.
21
  
 The significance of this entrainment of cardiovascular oscillations is not completely 
known, but breathing at 6 per minute has been shown to increase baroreflex sensitivity.
23
  
It is well established that baroreceptor abnormalities are associated with a poor prognosis 
in chronic heart failure and post-myocardial infarction.
24,25  
Lower rates of breathing 
  
(approximately 6 breaths per minute) have been shown to increase baroreflex sensitivity in 
heart failure, hypertension, diabetic autonomic neuropathy, and healthy controls.
26-28
  The 
baroreflex has a tonic influence on the chemoreflex, and it has been demonstrated that an 
enhanced baroreflex inhibits the chemoreflex while a depressed baroreflex results in an 
augmented chemoreflex.
23
  Slow deep breathing, through baroreflex augmentation, has 
been demonstrated to inhibit chemoreflex sensitivity with subsequent decrease of 
sympathetic tone.
23
  Research is needed to determine if regular meditation or slow 
breathing can over time increase baseline heart rate variability and baroreflex sensitivity 
through favorably affecting baseline autonomic tone.   
 The Anti-Inflammatory Reflex  
 Inflammation appears to play a central role in atherosclerotic plaque progression, 
vulnerability, and thrombogenicity
29,30
, and has been implicated in the pathophysiology of heart 
failure.
2  
Data suggests that the vagus nerve represents the efferent and afferent limbs of a 
cholinergic anti-inflammatory reflex that serves to decrease the detrimental effects of excessive 
proinflammatory stimulation.
31  
Vagal afferents sense peripheral inflammation and transmit 
action potentials from the periphery to the brain stem.  Efferent vagal activity is then enhanced 
and information relayed to the spleen and other organs where proinflammatory cytokines are 
inhibited and inflammation is limited.
31-33 
(Figure 2)  
 In addition to giving us a window into vagal efferent activity to the heart and 
parasympathetic tone, heart rate variability may also give us insight into the activity of the 
anti-inflammatory reflex.  Heart rate variability has been shown to be inversely related to 
inflammatory markers such as C-reactive protein and interleukin-6 (IL-6),
34,35
 which is 
likely reflective of a direct but complex relationship between vagal efferent activity to the 
  
heart and the efferent arm of the anti-inflammatory reflex.  Evidence suggests that the 
beneficial effects of exercise may be mediated, at least in part, through this anti-inflammatory 
reflex.
36  
The potential favorable effects of meditation on autonomic tone have the potential to 
produce similar beneficial effects through this reflex, though to date data is limited. 
The Mind-Heart Connection 
 The mind-heart connection is a complex and powerful relationship.  Brain injury is a well 
documented cause of dramatic electrocardiographic changes and cardiac lesions can result from 
disease of the central nervous system.
37
  Acute emotional stress has been associated with 
myocardial infarction, Takutsubo cardiomyopathy, arrhythmias, and sudden cardiac death, while 
chronic stress at work or at home has been associated with increased risk of incident 
cardiovascular disease.
38-42
  Anxiety and depression have been associated with increased risk of 
cardiovascular disease and are common in those with established cardiovascular disease; their 
added presence in established cardiovascular disease confers a poorer prognosis.
40,41,43-48
  
 There is a growing body of research which describes the mechanisms of mind-heart 
interactions.  The autonomic nervous system is one of the principal components of the mind-
heart connection and is one of the fundamental links between thoughts and emotions and the 
heart.
2
  The anti-inflammatory reflex provides an example of how autonomic function and 
inflammation interact and contribute to the mind-body communication network.
2 
 Major depressive disorder provides a good example of mind-heart interactions.  
Depression has been associated with sympathetic activation, decreased heart rate variability, and 
a proinflammatory response evidenced by increased inflammatory cytokines and C-reactive 
protein.
2,49
  In addition, depression activates the hypothalamic-pituitary adrenocortical (HPA) 
axis increasing cortisol production leading to insulin resistance, hypertension, and increased 
  
cardiovascular risk.  These factors create an environment that promotes vasoconstriction, 
endothelial damage, adhesion molecule expression, and platelet aggregation leading to increased 
risk of coronary artery disease, myocardial infarction, arrhythmias, heart failure, and sudden 
death.
2,40 
 Conversely, autonomic dysfunction and inflammation in the periphery have effects on the 
central nervous system.  It is known that pro-inflammatory stimulation has been associated with 
cognitive and mood changes as seen in the clinical example of interferon alpha induced 
depression.
2
  Autonomic imbalance and inflammation in chronic cardiac disease may contribute 
to cognitive and mood changes in diseases such as congestive heart failure.
2
  Further, an 
individual with autonomic dysfunction and inflammation as part of their inherent physiology 
may be at risk for both disorders of the mind and the cardiovascular system.  
 Subjectively reported benefits of long term meditation include relaxation and stress relief, 
increased concentration and attention, increased self-control, positive mood, emotional stability, 
increased resiliency to stress and negative events, as well as an overall enhanced psycho-
emotional balance.
1
  Objectively, there is evidence for meditation induced effects in the short and 
long term on functional and structural brain plasticity as well as beneficial effects on relaxation 
and stress relief.  There is also preliminary evidence for enhanced psycho-emotional balance and 
focused attention skills in those who practice meditation long term.
1
  In addition, there is 
promising data on the effects of meditation for disorders of mood and anxiety.
1
  Though very 
limited, data also suggests that meditation may result in improved psychological, hemodynamic, 
and immune responses to acute stress.
50,51 
 As meditation has probable beneficial effects on the mind and the autonomic nervous 
system, the practice may have a beneficial effect on the cardiovascular system.  Data are limited 
  
but promising on the effects of psychosocial interventions in cardiovascular disease.
40,41,52
  
Though not meditation based, a randomized controlled trial in women with coronary artery 
disease found that a group stress reduction program including relaxation training may prolong 
life independent of other prognostic factors.
52 
Blood Pressure 
 Acute Effects  
 The practice of meditation is associated with slower rates of breathing.  Slower breathing 
rates, independent of meditation, have been shown to acutely decrease blood pressure, an effect 
mediated at least in part through modulation of central and peripheral autonomic tone.
23
  Slow 
and controlled breathing at 6 breaths per minute has been demonstrated to significantly reduce 
the blood pressure of hypertensive subjects as well as in chronic heart failure subjects.
26,27
 
 Transcendental meditation® (TM®) is a widely used and researched meditation program 
where a word or phrase is mentally repeated as an object of focus.  TM® has been shown to 
decrease systolic blood pressure by 2.5 mmHg acutely in long term practitioners during  
practice.
53
  However, no acute effect on blood pressure was seen in a study of a similar 
meditation practice in healthy subjects during a long meditation.
54
  It was hypothesized that this 
negative result may have been due to achievement of optimal blood pressure at baseline, as the 
baseline blood pressures were less than national averages.    
 Factors that likely affect the acute blood pressure response to meditation include baseline 
sympathetic and parasympathetic tone, systemic vascular resistance, cardiac output, as well as 
skill in achieving a meditative state.  It is possible that those with baseline elevated systemic 
vascular resistance and/or autonomic imbalance may have a more dramatic acute effect.  
Ambulatory blood pressure recording of a hypertensive woman who practiced TM® showed a 
  
marked decrease in pressure during her meditation practice.
55
 (Figure 3)  
 Chronic Effects 
 Early studies demonstrated chronic reductions in blood pressure with meditation practice 
that disappeared relatively quickly after discontinuation of the practice.
56,57
  The effect of regular 
practice of TM® on baseline blood pressure has received considerable attention in recent 
decades.  Trials of TM® in those with normal blood pressure and those with hypertension have 
demonstrated significant reductions of systolic and diastolic pressures.
56,58-61
  However, many 
studies on TM® have been criticized for their quality and possible researcher bias.
62,63
 
 Three studies considered higher quality utilizing TM® demonstrated: 1.  a 3.4 mmHg 
reduction in systolic pressure with no significant change in diastolic pressure in patients with 
coronary artery disease; 2.  a 10.7 mmHg systolic reduction and 6.4 mmHg diastolic reduction in 
African American adults with hypertension; and 3.  a non-significant 3.1 mmHg systolic 
reduction with a significant 5.7 mmHg diastolic reduction again in African Americans with 
hypertension.
64-67
  In a 2009 study of TM® in college students, meditation did not have a 
significant effect on the blood pressure in the overall group.  However, in the group at high risk 
for hypertension, meditation significantly decreased systolic pressure by 5.0 mmHg and diastolic 
pressure by 2.8 mmHg, compared to increases of 1.3 mmHg systolic and 1.2 mmHg diastolic in 
controls.
68
 
 In a study of a contemplation meditation and breathing techniques in the treatment of 
pharmacologically untreated hypertension, office systolic pressure decreased by 15 mmHg in the 
treatment group with no change noted in the control group.
69
  The study utilized a very intensive 
intervention which included 40 minutes of meditation two times per day for 8 weeks.  A 
limitation of this and many controlled studies on meditation is the potential effect of placebo, as 
  
no validated “sham meditation technique” exists. 
Adrenal Hormones 
 Intuitively, as meditation produces physiologic results opposite from stress, lower levels 
of plasma catecholamines would be expected in those that meditate.  However, decreased levels 
of catecholamines in meditators has not been a consistent finding.
56
  There is data to suggest that 
the relaxation response may reduce the responsiveness of end organs to catecholamines.
56
  
Decreased cortisol levels in those that meditate have been a more consistent finding.
6,56
 
 A small study investigated the effects of meditation on norepinephrine levels in 19 
elderly patients with chronic heart failure with both reduced and preserved ejection fraction.
70
  
The meditation group was provided instruction in meditation and a 30 minute audiotape with 
meditation instructions to listen to twice per day for 12 weeks plus a weekly meeting, while the 
control group had only weekly meetings.  After the intervention, the meditation group 
significantly decreased their norepinephrine levels, a result not noted in the control group.  
Though promising, the study has limitations including a small sample size and higher baseline 
norepinephrine levels in the meditation group.  
Slow Breathing, Ventilation, and Exercise Capacity in Heart Failure 
 Respiratory dysfunction has been documented in congestive heart failure and can 
contribute to decreased exercise tolerance.
71-73
  In a study of 50 heart failure patients and 11 
controls, Bernardi and colleagues found that slow breathing at 6 breaths per minute increased 
oxygen saturation in heart failure patients, with evidence to suggest this rate was more effective 
in terms of gas exchange.
71
  In a follow-up study, 15 of the heart failure patients were assigned to 
one month of respiratory training or rest.  The goal of the training was to reduce the breathing 
rate and to mobilize in sequence the diaphragm, the lower chest, and the upper chest during 
  
inspiration with the reverse during expiration.  Patients underwent symptom-limited upright 
bicycle cardiopulmonary exercise testing before and after the training.  After one month of 
respiratory training, respiratory rate decreased from 13.4 (1.5) to 7.6 (1.9) (p< 0.001), peak 
oxygen consumption increased from 1157 (83) to 1368 (110) L/min (p< 0.05), and exercise 
time increased from 583 (29) to 615 (23) min/s (p< 0.05); changes that were not seen in the 
control group.
71
  Although the study is limited by small size, it does suggest the potential 
for respiratory training to improve exercise tolerance in heart failure. 
Clinical Trials in Established Cardiovascular Disease  
 Data on the effects of meditation on clinical endpoints in established cardiovascular 
disease are limited.  A small study (23 total patients) examined the effects of TM® in African 
Americans (≥55 years) with NYHA class II or III congestive heart failure and ejection fraction 
less than 40%.
74
  Subjects were randomized to instruction in TM® and two at home sessions of 
meditation for 15-20 minutes per day or health education classes with instructions to read or 
listen to music for 15-20 minutes two times per day.  The meditation group had significant 
improvements in the primary endpoint of six-minute walk test scores, improving their six-minute 
walk test score by 50.5 meters from baseline to 6 months compared to the health education group 
who had a decreased six-minute walk test score by 6.2 meters at 6 months (p=0.03).  There were 
also improvements in quality of life and depression in the meditation group.  Limitations of the 
study include the very small sample size and short follow up.   
 The Support Education and Research in Chronic Heart Failure Study (SEARCH) trial 
demonstrated promise for the role of meditation and mindfulness therapy in the treatment of 
heart failure.
75
  SEARCH was a prospective cohort study of 208 adults with left ventricular 
systolic dysfunction (ejection fraction less than or equal to 40%) and symptoms of congestive 
  
heart failure.  Patients were geographically assigned to either usual care or 2.25 hour weekly 
meetings in an 8 week course that included mindfulness and meditation training using 
mindfulness based stress reduction (MBSR) concepts, training in coping skills, and support 
group discussion.  Audiotapes with instructions for guided meditations were provided and 
patients in the treatment group agreed to practice these skills daily for 30 minutes.  Outcome 
measures were designed to evaluate effects on depression, psychosocial distress, and heart failure 
symptoms.  The mean age was 61, 70% of the patients were male, 46% had an ischemic etiology 
for their cardiomyopathy, and mean ejection fraction was 26%.  The treatment group had 
significantly improved symptoms of heart failure at one year compared to the control group.  
Those in the treatment group also had significantly lower levels of anxiety and depression; an 
effect that was attenuated at one year.  A limitation of the study was that the treatment group 
assignments were made by geography and not randomization.  More recently, TM® was found 
to decrease a composite of all-cause mortality, myocardial infarction, or stroke in African 
American patients with coronary heart disease.
76  
Though the results appear promising, 
analysis of the study and the statistics utilized raise questions making the data at best less 
than robust. 
Conclusion 
 Theoretical rationale and supporting data exist illustrating the potential of meditation 
practices to exert significant benefits on the cardiovascular system.  As our goals are to help 
patients live better and longer, there appears to be sufficient evidence regarding meditation 
practices to recommend them based on the former.  More high quality and unbiased studies of 
meditation practices on relevant endpoints in cardiovascular disease are needed including the 
effects of such practices on inflammation, baseline heart rate variability, arrhythmias, myocardial 
  
infarction, and cardiovascular mortality.  These studies may establish meditation as a beneficial 
adjunctive therapy specifically in the prevention and treatment of cardiovascular disease.  
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FIGURE LEGENDS 
Figure 1.  Amplitude of heart rate variability sub-bands (high frequency, low frequency, and very 
low frequency) during quiet sitting and deep meditation.  During quiet sitting heart rate 
variability is dispersed across the different frequencies.  During meditation in this subject, the 
appearance of a resonant peak with high amplitude occurs at a frequency of 0.1 Hz, likely related 
to breathing at the same rate.  Modified with permission from Phongsuphap S, Pongsupap Y, 
Chandanamattha P, Lursinsap C Changes in heart rate variability during concentration 
meditation Int J Cardiol. 2008 Nov 28;130(3):481-4. 
 
Figure 2.  Efferent Limb of the Anti-Inflammatory Reflex.  Efferent vagal activity leads to 
acetylcholine (ACh) release in organs of the reticuloendothelial system resulting in inhibition of 
pro-inflammatory cytokine release by tissue macrophages.  Modified with permission from 
Tracey KJ. The inflammatory reflex. Nature. 2002 Dec 19-26;420(6917):853-9 
 
Figure 3.  Ambulatory blood pressure monitoring of a hypertensive woman that had a striking 
daytime blood pressure decrease to values lower than that during sleep.  Upon review, the 
decrease corresponded to the woman’s meditation practice.  Reprinted with permission from 
Dear JW, Gough K, Webb, DJ. Images in medicine. Transcendental Meditation and 
Hypertension. Postgrad Med J 2008;84:417 
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